Search

Your search keyword '"Charlton, Peter"' showing total 154 results

Search Constraints

Start Over You searched for: Author "Charlton, Peter" Remove constraint Author: "Charlton, Peter" Database Unpaywall Remove constraint Database: Unpaywall
154 results on '"Charlton, Peter"'

Search Results

1. Developing technologies to assess vascular ageing: a roadmap from VascAgeNet

4. Contributors

6. The feasibility of population screening for paroxysmal atrial fibrillation using handheld ECGs

7. Reliability of single-lead electrocardiogram interpretation to detect atrial fibrillation: insights from the SAFER Feasibility Study

10. QRS detection in single-lead, telehealth electrocardiogram signals: benchmarking open-source algorithms

12. The 2023 wearable photoplethysmography roadmap

14. Arterial pulse wave modelling and analysis for vascular age studies: a review from VascAgeNet

15. Data from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

16. Supplemental Table S1 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

17. Supplemental Figure S3 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

18. Supplemental Figure S2 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

19. Supplemental Table S3 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

20. Supplemental Figure S2 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

21. Supplemental Table S2 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

22. Supplemental Table S2 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

23. Data from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

24. Supplemental Figure S1 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

25. Supplemental Table S1 from ATR Inhibitors VE-821 and VX-970 Sensitize Cancer Cells to Topoisomerase I Inhibitors by Disabling DNA Replication Initiation and Fork Elongation Responses

28. Vascular ageing: moving from bench towards bedside

36. Assessing hemodynamics from the photoplethysmogram to gain insights into vascular age: a review from VascAgeNet

49. Estimating central blood pressure from aortic flow: development and assessment of algorithms

Catalog

Books, media, physical & digital resources